27 February 2018
In
News
Stenting or by-pass? Diabetes maybe the decider.
The co-morbidity of diabetes seems to determine whether multi-vessel coronary artery disease is best managed by surgical by-pass or a stenting procedure – the data suggest that this particular group gets most benefit from a by-pass approach to revascularisation. It would be interesting to see if the same results are reproducible for diabetics with peripheral arterial disease where lower limb perfusion requires augmentation.